Cite
HARVARD Citation
Gordon, S. et al. (2020). Cost-effectiveness of pan-genotypic direct-acting antiviral regimens for treatment of chronic Hepatitis C in the United States. Expert review of pharmacoeconomics & outcomes research. pp. 251-257. [Online].